Page 2 - Best Astrocytoma doctors: TOP 61 doctors

Professor Keil specializes in advanced imaging and interventions for astrocytoma at Medical Center in Solingen.

• 22 years of experience in diagnostic and interventional radiology
• Trained under renowned radiologist Professor Christian K. Kuhl
• Expert in MRI, CT, and ultrasound-guided interventions
• Current Chief Physician of Diagnostic and Interventional Radiology

Chief Physician at a certified interdisciplinary cancer center – Phd Viola Fox specializes in advanced treatments for astrocytoma.

• Expert in chemotherapy, immunotherapy, and targeted therapy
• Qualified specialist in genetics with molecular diagnostics expertise
• Active in molecular biology research for innovative cancer treatments
• Member of German and American oncology societies

Prof. Elke Jaeger has performed 1,100+ oncology procedures and is ranked among Germany's best oncologists for 41 years of experience.

• Head of Oncology and Hematology at Nordwest Clinic
• Specializes in sarcoma treatment
• Professor of medical oncology and hemato-oncology
• Member of EORTC expert commission

Dr. Felix Bokstein leads the Neurooncology Clinic at Ichilov – one of Israel's largest and most advanced hospitals, focusing specifically on brain tumors.

• His primary focus is on treating complex brain and spinal cord tumors.
• As Head of Clinic, he oversees a dedicated neuro-oncology unit.
• Experience includes managing gliomas, astrocytomas, and other CNS malignancies.
• Integrates chemotherapy, targeted therapies, and clinical trial options into treatment plans.

Professor Zvi Ram heads the European Association of Neurosurgical Societies (EANS) – a top-level role that highlights his leadership in the field.

• He specializes in minimally invasive surgery and brain mapping techniques
• Expert in neurosurgical operations, including deep brain stimulation (DBS)
• Performs image-guided neurosurgery for brain tumors, trained in Greece and Switzerland
• Leads research into gene-based therapies for brain cancer
• Honored with the Borenstein Award from the Brain & Behavior Research Foundation

Dr. Yildiz has published extensively on neuroendocrine tumors and rare oncological cases, with research featured in international medical journals.

• Specializes in neuroendocrine tumors and rare cancer presentations
• Published 17+ peer-reviewed articles on oncology topics
• Works at Medipol Mega University Hospital

Prof. Wolfgang Köstler specializes in targeted cancer therapies, focusing on breast and gynecologic malignancies at Wiener Privatklinik.

• Over 22 years of experience of experience in medical oncology
• Expert in biomarker development and tumor biology
• Associate Professor at Medical University of Vienna
• Deputy Head of Clinical Division of Oncology

Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.

• Internal Medicine Specialist with extensive oncology experience
• Practiced at Ankara Oncology Clinic and Erzurum Regional Training Hospital
• Graduated from Selcuk University Faculty of Medicine
• Promoted to Associate Professor in 2016

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Specializing in astrocytoma and trained at top Turkish medical institutions – Dr. Alemdar brings evidence-based oncology care to Medical Park Antalya Hospital Complex.

• Completed medical oncology training at Akdeniz University
• 20 years of experience treating cancer in hospital and university settings
• Extensive experience at training and research hospitals
• Works alongside multidisciplinary teams for comprehensive treatment

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Assoc. Prof. Nail Paksoy brings extensive expertise in medical oncology, specializing in astrocytoma treatments at Istanbul Medipol University.

• ESMO Board Certified in Medical Oncology
• Active participant in international clinical trials for cancer treatments
• Published numerous research articles on innovative oncology therapies

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Defined the first strict criteria for diagnosing paraneoplastic neurological syndromes – a key advance in neuro-oncology. Dr. Graus is an emeritus investigator at IDIBAPS.

• Former chief of neurology at Hospital Clinic, Barcelona
• Founder and past president of the European Association of Neuro-Oncology
• PhD from Universitat Autònoma de Barcelona
• Specializes in gliomas and primary brain lymphomas

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.